Related Experiment Video
Updated: Jan 29, 2026

Quantifying the Frequency of Tumor-propagating Cells Using Limiting Dilution Cell Transplantation in Syngeneic Zebrafish
Published on: July 14, 2011
Interferon Regulatory Factor 3-Mediated Signaling Limits Middle-East Respiratory Syndrome (MERS) Coronavirus
Arinjay Banerjee1, Darryl Falzarano2,3, Noreen Rapin4
1Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada. banera9@mcmaster.ca.
Abstract:
Insectivorous bats are speculated to be ancestral hosts of Middle-East respiratory syndrome (MERS) coronavirus (CoV). MERS-CoV causes disease in humans with thirty-five percent fatality, and has evolved proteins that counteract human antiviral responses. Since bats experimentally infected with MERS-CoV do not develop signs of disease, we tested the hypothesis that MERS-CoV would replicate less efficiently in bat cells than in human cells because of its inability to subvert antiviral responses in bat cells. We infected human and bat (Eptesicus fuscus) cells with MERS-CoV and observed that the virus grew to higher titers in human cells. MERS-CoV also effectively suppressed the antiviral interferon beta (IFNβ) response in human cells, unlike in bat cells. To determine if IRF3, a critical mediator of the interferon response, also regulated the response in bats, we examined the response of IRF3 to poly(I:C), a synthetic analogue of viral double-stranded RNA. We observed that bat IRF3 responded to poly(I:C) by nuclear translocation and post-translational modifications, hallmarks of IRF3 activation. Suppression of IRF3 by small-interfering RNA (siRNA) demonstrated that IRF3 was critical for poly(I:C) and MERS-CoV induced induction of IFNβ in bat cells. Our study demonstrates that innate antiviral signaling in E. fuscus bat cells is resistant to MERS-CoV-mediated subversion.
Insights
Insectivorous bats may host Middle-East respiratory syndrome coronavirus (MERS-CoV). Bat cells resist MERS-CoV by maintaining antiviral interferon beta (IFNβ) responses, unlike human cells.
Area of Science:
- Virology
- Immunology
- Bat Biology
Background:
- Insectivorous bats are suspected ancestral hosts of MERS-CoV.
- MERS-CoV has a high fatality rate in humans (35%) and counteracts human antiviral responses.
- Bats infected with MERS-CoV show no disease signs, suggesting bats possess effective antiviral mechanisms.
Purpose of the Study:
- To test if MERS-CoV replicates less efficiently in bat cells due to an inability to subvert bat antiviral responses.
- To investigate the role of interferon beta (IFNβ) and IRF3 in bat antiviral immunity against MERS-CoV.
Main Methods:
- Infection of human and bat (Eptesicus fuscus) cells with MERS-CoV.
- Measurement of viral titers and IFNβ response.
- Analysis of IRF3 activation in response to poly(I:C) (a viral RNA mimic).
- IRF3 knockdown using small-interfering RNA (siRNA).
Main Results:
- MERS-CoV replicated to higher titers in human cells compared to bat cells.
- MERS-CoV suppressed IFNβ response in human cells but not in bat cells.
- Bat IRF3 activation (nuclear translocation, post-translational modifications) was observed upon poly(I:C) stimulation.
- IRF3 was essential for IFNβ induction in bat cells against MERS-CoV and poly(I:C).
Conclusions:
- Bat innate antiviral signaling, specifically the IRF3-IFNβ pathway, is resistant to MERS-CoV-mediated suppression.
- Eptesicus fuscus bat cells exhibit robust antiviral responses against MERS-CoV, contributing to their asymptomatic infection.
- Understanding these bat antiviral mechanisms could inform strategies against MERS-CoV in humans.
Related Concept Videos
Transcription Factors
Cis-regulatory Sequences
Limiting Reactant
What is Cell Signaling?
Cell-surface Signaling
The Number e as a Limit

